Zoetis

PARSIPPANY, N.J., December 5, 2025 — Zoetis Inc. announced that Health Canada has approved Portela™ (relfovetmab injection) for the...

PARSIPPANY, N.J. — December 11, 2025 — Zoetis Inc., the world’s leading animal health company, announced that its Board...

SAN FRANCISCO, December 3, 2025 — Junevity today announced the expansion of its seed funding round to $20 million...

PARSIPPANY, N.J., December 3, 2025 — Zoetis has highlighted its R&D leadership, expanding innovation strategy, and long-term growth outlook...

Parsippany, New Jersey / Brussels, October 29, 2025 — Zoetis Inc. today announced that the European Commission has granted...

Parsippany, NJ – September 30, 2025 – Zoetis Inc. announced that Dectomax®-CA1 Injectable has received conditional approval from the...